文献速递瓣膜外科先天性心脏病外科

成人先天性心脏病多瓣膜再手术的30年单中心结局

Outcomes following multivalve reoperation in adults with congenital heart disease: A 30-year, single-center study.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-07-20

该研究回顾1993至2022年1960例成人先天性心脏病再次正中开胸患者,其中502例(26%)行2个及以上瓣膜干预。择期手术早期死亡率为2.7%,总体为4.2%;非择期手术和主要复杂性先心病独立关联早期死亡。中位随访14年,1年、5年、10年生存率分别为93.6%、89.3%、79.5%。

要点

  • 择期多瓣膜再手术早期死亡率低(2.7%),总体早期死亡率为4.2%。
  • 非择期手术和主要复杂性先心病独立关联早期死亡。
  • 年龄、心室功能障碍、冠心病、肾衰竭、双瓣膜置换、非择期手术和转机时间独立关联总体死亡。

核心结论

  • 多瓣膜干预常见,择期情况下早期死亡率低。
  • 在心室功能障碍前转诊并择期手术可优化结局。

研究设计与样本

  • 1993至2022年单中心回顾性研究,1960例成人先天性心脏病患者再次正中开胸,其中502例(26%)行2个及以上瓣膜干预构成研究队列。

主要发现

  • 中位年龄39(27-51)岁,275例(55%)为女性。
  • 第二次、第三次、第四次、第五次及以上开胸分别为265例(53%)、135例(27%)、75例(15%)、27例(5%)。
  • 干预2个、3个、4个瓣膜分别为436例(87%)、62例(12%)、4例(1%)。
  • 最常见组合为肺动脉瓣和三尖瓣241例(48%),其次二尖瓣和三尖瓣85例(17%)、主动脉瓣和肺动脉瓣42例(8%)、主动脉瓣和二尖瓣41例(8%)。
  • 总体早期死亡率为4.2%,择期手术为2.7%;非择期手术和主要复杂性先心病独立关联早期死亡。

临床怎么用

  • 在心室功能障碍前转诊并择期手术可优化多瓣膜再手术结局。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: As patients with congenital heart disease increasingly live into adulthood, reoperative surgery is frequently required. Although half of these are valve-related procedures, little is known regarding early and late outcomes, and factors associated with adverse outcomes. METHODS: From 1993 to 2022, a total of 1960 adult patients with congenital heart disease underwent repeat median sternotomy at our institution. Of these, 502 patients (26%) underwent intervention on 2 or more valves and constituted the study cohort. RESULTS: The median age was 39 (27-51) years, and 275 patients (55%) were female. A second sternotomy was performed in 265 patients (53%), a third sternotomy was performed in 135 patients (27%), a fourth sternotomy was performed in 75 patients (15%), and a fifth or more sternotomy was performed in 27 patients (5%). Interventions were performed on 2 valves in 436 patients (87%), 3 valves in 62 patients (12%), and 4 valves in 4 patients (1%). The most common combinations were pulmonary and tricuspid in 241 patients (48%), followed by mitral and tricuspid in 85 patients (17%), aortic and pulmonary in 42 patients (8%), and aortic and mitral in 41 patients (8%). Early mortality was 4.2% overall and 2.7% for elective operations. Nonelective operations and congenital heart disease of major complexity were independently associated with early mortality. Median follow-up was 14 years. One, 5-, and 10-year survivals were 93.6%, 89.3%, and 79.5%, respectively. Factors independently associated with overall mortality were age, ventricular dysfunction, coronary artery disease, renal failure, double valve replacement, nonelective operations, and bypass time. CONCLUSIONS: Multiple valve interventions are common and confer low early mortality in the elective setting. Referral before ventricular dysfunction and in an elective setting optimizes outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Abdelrehim AA, Stephens EH, Holst KA, et al. Outcomes following multivalve reoperation in adults with congenital heart disease: A 30-year, single-center study. J Thorac Cardiovasc Surg. 2024. PMID: 39038781. doi:10.1016/j.jtcvs.2024.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。